Clarius Group’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
Clarius Group's EDIT Position: Q4 2017 in Review
Clarius Group sold out of Editas Medicine (EDIT) in Q4 2017, closing a stake of 87,231 shares — an estimated $2.09M sold.
Clarius Group first reported a position in EDIT in Q3 2016 and held it in 5 quarters. The position peaked at $2.09M in Q3 2017. 151 funds tracked by Wall St. Rank hold EDIT as of Q4 2017.
- Clarius Group reported no remaining Editas Medicine position as of Q4 2017 after selling out during the quarter.
- Clarius Group sold 87,231 Editas Medicine shares in Q4 2017, an estimated $2.09M.
- Clarius Group first reported a position in Editas Medicine in Q3 2016 and held it in 5 quarters.
- Clarius Group's Editas Medicine position peaked at $2.09M in Q3 2017.
- 151 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2017.
Based on Clarius Group's 13F filing for Q4 2017, filed 9 Feb 2018.